Neogen Corp (NEOG)
12.40
+0.16
(+1.27%)
USD |
NASDAQ |
May 02, 13:45
Neogen Net Income (Quarterly): -2.022M for Feb. 29, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| February 29, 2024 | -2.022M |
| November 30, 2023 | -3.487M |
| August 31, 2023 | 1.503M |
| May 31, 2023 | 5.572M |
| February 28, 2023 | 8.19M |
| November 30, 2022 | -41.84M |
| August 31, 2022 | 5.209M |
| May 31, 2022 | 14.96M |
| February 28, 2022 | 5.443M |
| November 30, 2021 | 10.83M |
| August 31, 2021 | 17.08M |
| May 31, 2021 | 15.76M |
| February 28, 2021 | 13.38M |
| November 30, 2020 | 15.88M |
| August 31, 2020 | 15.86M |
| May 31, 2020 | 16.35M |
| February 29, 2020 | 12.20M |
| November 30, 2019 | 16.28M |
| August 31, 2019 | 14.65M |
| May 31, 2019 | 15.82M |
| February 28, 2019 | 13.07M |
| November 30, 2018 | 16.05M |
| August 31, 2018 | 15.24M |
| May 31, 2018 | 17.54M |
| February 28, 2018 | 16.59M |
| Date | Value |
|---|---|
| November 30, 2017 | 17.10M |
| August 31, 2017 | 11.91M |
| May 31, 2017 | 12.47M |
| February 28, 2017 | 10.29M |
| November 30, 2016 | 11.15M |
| August 31, 2016 | 9.881M |
| May 31, 2016 | 9.857M |
| February 29, 2016 | 8.311M |
| November 30, 2015 | 9.073M |
| August 31, 2015 | 9.323M |
| May 31, 2015 | 9.384M |
| February 28, 2015 | 7.454M |
| November 30, 2014 | 7.806M |
| August 31, 2014 | 8.883M |
| May 31, 2014 | 7.537M |
| February 28, 2014 | 6.575M |
| November 30, 2013 | 6.207M |
| August 31, 2013 | 7.839M |
| May 31, 2013 | 7.032M |
| February 28, 2013 | 6.652M |
| November 30, 2012 | 6.793M |
| August 31, 2012 | 6.714M |
| May 31, 2012 | 6.028M |
| February 29, 2012 | 5.244M |
| November 30, 2011 | 5.237M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-41.84M
Minimum
Nov 2022
17.08M
Maximum
Aug 2021
7.880M
Average
12.79M
Median
Net Income (Quarterly) Benchmarks
| Moderna Inc | 217.00M |
| SIGA Technologies Inc | 72.26M |
| Syros Pharmaceuticals Inc | -64.38M |
| Disc Medicine Inc | -23.58M |
| Amylyx Pharmaceuticals Inc | 4.731M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 228.81M |
| Total Expenses (Quarterly) | 216.79M |
| EPS Diluted (Quarterly) | -0.01 |
| Enterprise Value | 3.373B |
| Gross Profit Margin (Quarterly) | 51.08% |
| Profit Margin (Quarterly) | -0.88% |
| Earnings Yield | 0.05% |
| Operating Earnings Yield | 2.57% |
| Normalized Earnings Yield | 0.1695 |